Atlas Trials

A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers

Clinical trial NCT00931073 · COMPLETED

Trial details

NCT number
NCT00931073
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's DiseaseHuntington's Disease
Start date
2009-07-01
Primary completion
2009-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.